Teva Pharmaceutical Industries (TEVA) Change in Taxes (2016 - 2017)
Historic Change in Taxes for Teva Pharmaceutical Industries (TEVA) over the last 6 years, with Q1 2017 value amounting to $54.0 million.
- Teva Pharmaceutical Industries' Change in Taxes fell 7631.58% to $54.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was $347.0 million, marking a year-over-year decrease of 5422.16%. This contributed to the annual value of $521.0 million for FY2016, which is 1782.33% down from last year.
- As of Q1 2017, Teva Pharmaceutical Industries' Change in Taxes stood at $54.0 million, which was down 7631.58% from $57.0 million recorded in Q4 2016.
- In the past 5 years, Teva Pharmaceutical Industries' Change in Taxes registered a high of $249.0 million during Q4 2015, and its lowest value of -$222.0 million during Q2 2013.
- Its 5-year average for Change in Taxes is $103.4 million, with a median of $104.0 million in 2015.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Change in Taxes surged by 123333.33% in 2014 and then tumbled by 7710.84% in 2016.
- Over the past 5 years, Teva Pharmaceutical Industries' Change in Taxes (Quarter) stood at $114.0 million in 2013, then surged by 63.16% to $186.0 million in 2014, then skyrocketed by 33.87% to $249.0 million in 2015, then tumbled by 77.11% to $57.0 million in 2016, then decreased by 5.26% to $54.0 million in 2017.
- Its Change in Taxes was $54.0 million in Q1 2017, compared to $57.0 million in Q4 2016 and $207.0 million in Q3 2016.